Alignment Healthcare, Inc.
ALHC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2,703,561 | $1,823,630 | $1,434,159 | $1,167,773 |
| % Growth | 48.3% | 27.2% | 22.8% | – |
| Cost of Goods Sold | $2,406,870 | $1,622,600 | $1,249,879 | $1,039,041 |
| Gross Profit | $296,691 | $201,030 | $184,280 | $128,732 |
| % Margin | 11% | 11% | 12.8% | 11% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $363,138 | $0 | $0 | $0 |
| SG&A Expenses | $368,894 | $307,433 | $295,646 | $290,991 |
| Sales & Mktg Exp. | $5,756 | $0 | $0 | $0 |
| Other Operating Expenses | $29,352 | $21,414 | $17,273 | $15,813 |
| Operating Expenses | $398,246 | $328,847 | $312,919 | $306,804 |
| Operating Income | -$101,555 | -$127,817 | -$128,639 | -$178,072 |
| % Margin | -3.8% | -7% | -9% | -15.2% |
| Other Income/Exp. Net | -$26,495 | -$20,378 | -$20,661 | -$17,214 |
| Pre-Tax Income | -$128,050 | -$148,195 | -$149,300 | -$195,286 |
| Tax Expense | $21 | -$22 | $339 | $0 |
| Net Income | -$128,035 | -$148,017 | -$149,547 | -$195,286 |
| % Margin | -4.7% | -8.1% | -10.4% | -16.7% |
| EPS | -0.67 | -0.79 | -0.83 | -1.14 |
| % Growth | 15.2% | 4.8% | 27.2% | – |
| EPS Diluted | -0.67 | -0.79 | -0.83 | -1.14 |
| Weighted Avg Shares Out | 190,794 | 186,215 | 181,213 | 171,957 |
| Weighted Avg Shares Out Dil | 190,794 | 186,215 | 181,213 | 171,957 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $23,547 | $21,231 | $18,289 | $17,443 |
| Depreciation & Amortization | $27,062 | $21,668 | $17,486 | $16,033 |
| EBITDA | -$77,441 | -$105,296 | -$113,525 | -$161,810 |
| % Margin | -2.9% | -5.8% | -7.9% | -13.9% |